EDGAR Filing Documents for 0001144204-08-066546

Form 8-K - Current report:

SEC Accession No. 0001144204-08-066546

Filing Date

2008-11-25

Accepted

2008-11-25 08:35:08

Documents

Period of Report

2008-11-19

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		v133269_8k.htm	8-K	54428
2		v133269_ex10-1.htm	EX-10.1	842650
3		v133269_ex10-2.htm	EX-10.2	180328
4		v133269_ex10-3.htm	EX-10.3	434434
5		v133269_ex10-4.htm	EX-10.4	449286
6		v133269_ex10-5.htm	EX-10.5	95715
7		v133269_ex10-6.htm	EX-10.6	104924
8		v133269_ex10-7.htm	EX-10.7	30391
9		v133269_ex10-8.htm	EX-10.8	30186
10		v133269_ex10-9.htm	EX-10.9	123646
11		v133269_ex99-1.htm	EX-99.1	11820
	Complete submission text file	0001144204-08-066546.txt		2359754

Mailing Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019

Business Address 810 SEVENTH AVENUE 4TH FLOOR NEW YORK NY 10019 (212) 582-3950

MANHATTAN PHARMACEUTICALS INC (Filer) CIK: 0001001316 (see all company filings)